Biofilm Development by Clinical Strains of Non-pigmented Rapidly Growing Mycobacteria
Overview
Authors
Affiliations
The relationship between clinical significance of non-pigmented, rapidly growing mycobacteria (NPRGM), in vitro biofilm development and sliding motility was evaluated in this study. One hundred and sixty-eight clinical strains of NPRGM were included. Forty-one of these were clinically significant isolates. Biofilm was formed by 123 strains. Seventy-six biofilm-positive and 25 biofilm-negative strains showed sliding motility. There was a relationship between clinical significance and biofilm development (p <0.000,001), sliding motility (p 0.0037) and species (p <0.000,001). No relationship was found between motility and biofilm development. The ability to develop biofilm is a characteristic that can have importance in the development of infections caused by NPRGM.
Huang Y, Huang C, Huang Y, Yen C, Hsu C Microbiol Spectr. 2024; :e0019924.
PMID: 38934606 PMC: 11302017. DOI: 10.1128/spectrum.00199-24.
A laboratory perspective on biofilm culture, characterization and drug activity testing.
Meliefste H, Mudde S, Ammerman N, de Steenwinkel J, Bax H Front Microbiol. 2024; 15:1392606.
PMID: 38690364 PMC: 11058659. DOI: 10.3389/fmicb.2024.1392606.
Senhaji-Kacha A, Akir A, Broncano-Lavado A, Esteban J Rev Esp Quimioter. 2024; 37(3):266-269.
PMID: 38602224 PMC: 11094638. DOI: 10.37201/req/014.2024.
Healthcare-Associated Infections Caused by Mycolicibacterium neoaurum.
Shapiro K, Cross S, Morton T, Inaba H, Holland A, Fasipe F Emerg Infect Dis. 2023; 29(8).
PMID: 37486155 PMC: 10370869. DOI: 10.3201/eid2908.230007.
Munoz-Egea M, Akir A, Esteban J Biofilm. 2023; 5:100107.
PMID: 36798742 PMC: 9925856. DOI: 10.1016/j.bioflm.2023.100107.